- Home
- ANIP vs ECAT Comparison
ANIP vs ECAT Comparison
Compare ANIP & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- ECAT
- Stock Information
- Founded
- ANIP 2001
- ECAT 2021
- Country
- ANIP United States
- ECAT United States
- Employees
- ANIP N/A
- ECAT N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- ECAT Trusts Except Educational Religious and Charitable
- Sector
- ANIP Health Care
- ECAT Finance
- Exchange
- ANIP Nasdaq
- ECAT Nasdaq
- Market Cap
- ANIP 2.0B
- ECAT 1.7B
- IPO Year
- ANIP N/A
- ECAT N/A
- Fundamental
- Price
- ANIP $98.30
- ECAT $16.76
- Analyst Decision
- ANIP Strong Buy
- ECAT
- Analyst Count
- ANIP 9
- ECAT 0
- Target Price
- ANIP $86.00
- ECAT N/A
- AVG Volume (30 Days)
- ANIP 488.4K
- ECAT 278.6K
- Earning Date
- ANIP 11-07-2025
- ECAT 01-01-0001
- Dividend Yield
- ANIP N/A
- ECAT 9.20%
- EPS Growth
- ANIP N/A
- ECAT N/A
- EPS
- ANIP N/A
- ECAT 2.39
- Revenue
- ANIP $747,399,000.00
- ECAT N/A
- Revenue This Year
- ANIP $39.32
- ECAT N/A
- Revenue Next Year
- ANIP $9.62
- ECAT N/A
- P/E Ratio
- ANIP N/A
- ECAT $7.15
- Revenue Growth
- ANIP 38.68
- ECAT N/A
- 52 Week Low
- ANIP $52.50
- ECAT $14.02
- 52 Week High
- ANIP $99.50
- ECAT $17.30
- Technical
- Relative Strength Index (RSI)
- ANIP 77.93
- ECAT 56.49
- Support Level
- ANIP $96.50
- ECAT $16.65
- Resistance Level
- ANIP $99.50
- ECAT $16.83
- Average True Range (ATR)
- ANIP 2.17
- ECAT 0.15
- MACD
- ANIP -0.33
- ECAT 0.01
- Stochastic Oscillator
- ANIP 87.17
- ECAT 76.83
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.